SER-155 Transplant Infection Data Enter Peer Reviewed Record

Company Seres Therapeutics Event Type Peer-reviewed publication (Nature Medicine) Modality Live biotherapeutic (microbiome) Asset SER-155 Target Gut pathogen expansion and mucosal barrier Disease Area Bloodstream infection after allogeneic HCT Summary A Nature Medicine Phase 1b paper published online November 3 reports fewer bloodstream infections through…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *